Delivery Order SPE2DB20D2104-SPE2DB24FT96J
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,691.17 firm fixed-price delivery order is for RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,537.04, is for the delivery of RYTARY ER 61.25 MG-245 MG capsules. The contract has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S medication. The contract has a ceiling value of $1,244.90 and runs through October 29, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of RYTARY ER 36.25 MG-145 MG capsules to the U.S. Department of Defense's Medical Supply Chain. The $10,036.91 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of September 17, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds several Indefinite Delivery...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a firm fixed-price delivery order contract worth $13,114.31 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Rytary ER 48.75 mg-195 mg capsules, a pharmaceutical product used to treat certain medical conditions. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,552.40 firm fixed-price contract is for the delivery of Rytary ER 48.75 mg-195 mg capsules. The contract has a period of performance through July 29, 2024 and is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office division, has been awarded numerous Indefinite Delivery Contracts...
- This is a $36,865.27 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product, with a period of performance through May 13, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,072.33 firm fixed price delivery order is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product. This contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,957.88 firm fixed-price delivery order is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product, with a performance period through March 16, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award, with an ID of SPE2DB20D2002|SPE2DB24FL37G, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,576.27 Firm Fixed Price delivery order is for the pharmaceutical product Rytary ER 48.75 mg-195 mg Capsules, 100-count. The contract has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT96JDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $1,272.84 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide RYTARY ER 36.25 MG-145 MG capsules. This contract has an ultimate completion date of May 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/1/24 |